CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Hexal Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial TranslocationEURO CELTIQUEMay 14, 2020
Crenolanib For Treating Flt3 Mutated Proliferative DisordersAROG PHARMACEUTICALSDec 7, 2018

Top competitors of Hexal Pharma

Top competitors of Hexal Pharma based on patent oppositions.